Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Visual Agnosia01:12

Visual Agnosia

Visual agnosia is a condition characterized by the inability to recognize visually presented objects despite having normal vision. For instance, a person with visual agnosia can describe the shape and color of an object but cannot identify or name it. This impairment does not affect their visual field, acuity, color vision, brightness discrimination, language, or memory. An example of this condition in a social setting is someone at a dinner party asking for "that silver thing with a round end"...
Prosopagnosia01:24

Prosopagnosia

Prosopagnosia, also known as face blindness, is the inability to recognize faces. In severe cases, individuals with prosopagnosia may not recognize close family members, including parents and spouses, by their faces. For instance, someone with prosopagnosia might walk past their child in a crowd, only realizing their mistake upon noticing their child's distinctive backpack or favorite jacket. Prosopagnosia specifically impairs facial recognition, while the recognition of other objects or...
Hindsight Biases01:12

Hindsight Biases

Hindsight bias leads you to believe that the event you just experienced was predictable, even though it really wasn’t. In other words, you knew all along that things would turn out the way they did. Can you relate this to the phrase "Hindsight is 20/20" now?
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category, whereas...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of interleukin-6 in diabetic retinal disease: pathophysiology and therapeutic targeting.

Frontiers in immunology·2026
Same author

Interleukin 6 Inhibition With Vamikibart for Uveitic Macular Edema: The Phase 1 DOVETAIL Nonrandomized Clinical Trial.

JAMA ophthalmology·2026
Same author

Peripheral ulcerative keratitis (PUK) in autoimmune diseases: a severe ocular manifestation not always associated with systemic disease activity.

European journal of internal medicine·2026
Same author

More Than Meets the Eye: A Case of Delayed Sequential Bilateral Vision Loss.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2025
Same author

Retinal and Optic Nerve Integrity After Endoscopic Transorbital Skull Base Surgery Assessed by Optical Coherence Tomography.

Neurosurgery·2025
Same author

Comparison of Four Lens Power Formulas for Sutureless Scleral-Fixated Carlevale Lens.

Clinical ophthalmology (Auckland, N.Z.)·2025
Same journal

Trends in pediatric uveitis: A systematic review and meta-epidemiological investigation of geographic, economic, and climate factors.

Survey of ophthalmology·2026
Same journal

Efficacy and safety of different intraocular therapies for non-infectious uveitis: A network meta-analysis.

Survey of ophthalmology·2026
Same journal

Macular telangiectasia masqueraders.

Survey of ophthalmology·2026
Same journal

Utilization of anterior segment optical coherence tomography in childhood glaucoma: A systematic review.

Survey of ophthalmology·2026
Same journal

Peripapillary pachychoroid syndrome: Clinical and imaging features, diagnostic differentiation and therapeutic strategies.

Survey of ophthalmology·2026
Same journal

Prognostic factors and postoperative outcomes in pediatric cataract patients: A systematic review and meta-analysis.

Survey of ophthalmology·2026
See all related articles

Related Experiment Video

Updated: May 28, 2026

Setup and Execution Of the Blindfolded Code Training Exercise
05:25

Setup and Execution Of the Blindfolded Code Training Exercise

Published on: March 29, 2019

Blind runner.

Laura Pelegrín1, Marina Mesquida, Amanda Rey

  • 1Department of Ophthalmology, Hospital Clínic de Barcelona, Barcelona, Spain. laurapelegrin79@hotmail.com

Survey of Ophthalmology
|October 25, 2011
PubMed
Summary
This summary is machine-generated.

Takayasu arteritis (TA) rarely presents with ocular ischemic syndrome and ischemic optic neuropathy. This case highlights severe ocular and cerebral ischemia as initial TA manifestations in a Pakistani man.

More Related Videos

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision
09:29

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

Published on: February 11, 2014

Related Experiment Videos

Last Updated: May 28, 2026

Setup and Execution Of the Blindfolded Code Training Exercise
05:25

Setup and Execution Of the Blindfolded Code Training Exercise

Published on: March 29, 2019

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision
09:29

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

Published on: February 11, 2014

Area of Science:

  • Ophthalmology
  • Cardiology
  • Rheumatology

Background:

  • Takayasu arteritis (TA) is a rare, chronic inflammatory disease affecting large arteries, primarily the aorta and its branches.
  • Ocular manifestations in TA, though known, are infrequently reported as initial presenting symptoms.
  • The severity of ocular symptoms often correlates with the extent of vascular involvement in TA.

Observation:

  • A 42-year-old Pakistani man presented with bilateral ocular ischemic syndrome and unilateral ischemic optic neuropathy.
  • These severe ocular symptoms were the initial clinical presentation of Takayasu arteritis.
  • The patient also experienced significant cerebral ischemia.

Findings:

  • The case demonstrates a rare initial presentation of Takayasu arteritis.
  • Bilateral ocular ischemic syndrome and ischemic optic neuropathy were key indicators of underlying TA.
  • Severe ocular and cerebral ischemia underscore the systemic vascular impact of TA.

Implications:

  • Early recognition of ocular symptoms can be crucial for diagnosing Takayasu arteritis.
  • This case emphasizes the importance of considering TA in patients with unexplained severe ocular and cerebral ischemia.
  • Prompt diagnosis and management of TA are vital to prevent irreversible vision loss and neurological damage.